FTC Sues to Block Amgen's $28B Horizon Therapeutics Deal : v

The FTC said the acquisition would allow Amgen to entrench Horizon’s monopoly on medications for thyroid eye disease and chronic refractory gout.

Related Keywords

Illinois , United States , Lina Khan , Holly Vedova , Amgen Inc , Amgen , Activision Blizzard Inc , Microsoft Corp , Cigna Group Express Scripts , Health Corp , Intercontinental Exchange Inc , Horizon Therapeutics Plc , Knight Inc , Federal Trade Commission , Activision Blizzard , Intercontinental Exchange , Black Knight , Cigna Group , Express Scripts , Bloomberg Law ,